ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 242

WOMAC Pain Score Reflects Preceding Daily Pain Ratings in Knee Osteoarthritis Interventional Randomized Clinical Trials

Michael H. V. Nguyen1, Renita Evonne Yeasted2 and Thomas J. Schnitzer3, 1University of Washington School of Medicine, Seattle, WA, 2PM&R, Northwestern University, Chicago, IL, 3PM&R and Int Med, Northwestern University, Chicago, IL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Knee, OA and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pain: Basic and Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a validated and widely used instrument for assessing osteoarthritis (OA) knee and hip pain, stiffness and physical function.  The recall period for specific outcome measures is 48 hours.  This study aimed to examine the correlation between WOMAC pain score and reported actual pain levels one, two and 5 days prior to completing the WOMAC instrument.

Methods

Data were obtained from three OA studies:  an observational study (OBS) convenience sampling of OA and the placebo arm of two interventional randomized control trials (IRCTs).  All participants were ≥ 40 years of age, met the ACR definition for OA, and self-reported a minimum pain intensity of ≥ 4 on Numeric Rating Scale (NRS) for pain (0 – no pain; 10 – worst pain possible).  Participants were asked to report pain twice daily (IRCTs, electronic tablet) or three times daily (OBS, smartphone) over a 12-16 week period, and WOMAC was completed at regular clinic visits.  For each participant, mean pain ratings were calculated for the day of clinical exam, as well as 1 day, 2 days, and 5 days prior and compared to the WOMAC pain score for question 1.  Pearson’s correlation was computed to assess the relationship between WOMAC pain score and self-reported pain using Stata 13.

Results

In total, data were collected from 162 participants (123 studied in clinical trials and 39 studied in the observational study).  The demographics for all three groups were similar and typical of adults with OA.  Among clinical trial participants, there was a strong, positive correlation between WOMAC and self-reported pain for all time points [r=0.8505, n=392 (exam day); r=0.8482, n=474 (1 day prior); r=0.8575, n=415 (2 day prior); r=0.8173, n=267 (5 day prior); all values p < 0.05] (Figure 1).  Among observation study participants, there was a moderate, positive correlation between WOMAC and self-reported pain significant only at 1 day prior to exam [r=0.3741, n=56] (Figure 2). 

Conclusion

The findings of this study demonstrate a high correlation within individuals between WOMAC pain scores and self-reported daily preceding pain intensity in ICRT.  This correlation was independent of the look-back period (one, two or five days).  Less strong correlations were observed in OBS study settings.  These findings are consistent with lower daily pain variability in interventional trials than in the observational setting and have implications on assessing and managing pain in non-IRCT settings.


Disclosure:

M. H. V. Nguyen,
None;

R. E. Yeasted,
None;

T. J. Schnitzer,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/womac-pain-score-reflects-preceding-daily-pain-ratings-in-knee-osteoarthritis-interventional-randomized-clinical-trials/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology